Skip to content

Clinical trials

Completed Multiple Myeloma trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Completed Country / region: Netherlands Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20042
20063
20084
20091
20103
20115
20125
20133
20146
20154
20166
20177
20182
20195
20202
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene10
Janssen Research & Development, LLC10
Amgen5
Novartis Pharmaceuticals3
Amsterdam UMC, location VUmc2
Janssen-Cilag B.V.2
Millennium Pharmaceuticals, Inc.2
Radboud University Medical Center2
Stichting European Myeloma Network2
Takeda2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma64
Recurrence14
Neoplasms5
Neoplasms, Plasma Cell5
Hematologic Neoplasms3
Hodgkin Disease3
Febrile Neutropenia2
Leukemia, Hairy Cell2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Acute2

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.